Endometriosis ~ Abdominal Pain ~ Endo ~ Scar Tissue ~ Adhesions ~ Infertility ~ Hysterectomy
Showing posts with label Endometriosis cancer link. Show all posts
Showing posts with label Endometriosis cancer link. Show all posts

Wednesday, April 09, 2014

Author Hilary Mantel: 'It won’t all be novels now — it could be plays' ~ Writes with severe Endometriosis

"Mantel has written about the severe endometriosis that doctors failed to diagnose in her youth; how it caused the loss of her fertility and the doubling of her body weight in less than a year.
Now she says the condition defined her as a writer, indeed made her one. “You really live on the verge of panic because you don’t know what’s going on inside you. And when the pain isn’t there, you know it’s waiting for you. It’s why I became a writer in the first place. I don’t like to let people down and I couldn’t have gone into an office every day.
“Sometimes I’ve travelled [to author events] and gone on stage when any sensible person would have stayed at home. I have sat in car parks thinking, ‘Do I go in and do the talk or do I go to A&E?’"

Sunday, March 16, 2014

Transvaginal hydrolaparoscopy. as diagnostic tool Endometriosis Adhesions

 2012 Jul-Sep;16(3):461-5. doi: 10.4293/108680812X13462882736295.

Transvaginal hydrolaparoscopy.

Abstract

Transvaginal hydrolaparoscopy (THL) is being performed regularly in Europe and China, but rarely in the United States. The reasons may be physicians' unfamiliarity with the procedure and their uneasiness over potential rectal puncturing due to the proximity of the rectum to the vaginal trocar insertion site. THL has the advantage over hysterosalpingography (HSG) in that it allows for direct visualization of the tubal mucosa in addition to determining tubal patency. THL has advantages over traditional laparoscopy in that it does not require an abdominal incision and has the capability of being conducted in an outpatient office setting with local anesthesia. Studies have shown that THL has comparable accuracy to laparoscopy with 96.1% concordance between THL and laparoscopic findings. THL may be combined with chromopertubation and salpingoscopy. In addition to diagnostic purposes, THL may be used for operative intervention including adhesiolysis, endometriosis ablation, and ovarian drilling. Studies from France and China report the occurrence of rectal injury from 0% to1%. Despite the advantages of THL and low reports of rectal injury, THL has not gained popularity in the United States. The purpose of this article is to familiarize gynecologists in the United States with THL.
PMID:
 
23318074
 
[PubMed - indexed for MEDLINE] 
PMCID:
 
PMC3535799
 
Free PMC Article
Images from this publication.See all images (1)Free text

Figure 1.

Saturday, March 15, 2014

Wednesday, January 11, 2012

Baylor scientists receive $1.35 million from Ovarian Cancer Research Fund

Baylor scientists receive $1.35 million from Ovarian Cancer Research Fund


HOUSTON -- (January 9, 2012) -- Two Baylor College of Medicine researchers have received three-year grants totaling $1.35 million from the Ovarian Cancer Research Fund for studies directed toward earlier detection of ovarian cancer.

Ovarian cancer is the ninth most common cause of cancer among U.S. women and the fifth most common cause of cancer deaths in women. An estimated 22,000 will be diagnosed with the disorder this year and more than 15,000 will die of it.



"Investigating ARID1A
Over the next three years, Hawkins will research why some women with endometriosis (the growth of cells that usually line the uterus outside that organ, often on the ovary) go on to develop a kind of ovarian cancer known as endometrioid or clear cell ovarian cancer.

"Additionally, women with endometriosis-associated ovarian cancer have a better prognosis than women without endometriosis," she said.

She will look at a gene called ARID1A that may play a role in the transformation from endometriosis cells to ovarian cancer cells. How ARID1A plays a role in the formation of tumors is not yet understood, and Hawkins plans to study both benign and malignant human tissue to find mutations in ARID1A. She will work in cell cultures to determine if ARID1A leads to increased growth of cancer cells because of interaction with other cancer genes. She will create a mouse model to mimic the low levels of ARID1A and see how early tumors form as well as to study potential therapies."
Click here to read entire article: http://www.bcm.edu/news/item.cfm?newsID=5022

Saturday, December 03, 2011

Rise in Dangerous Type of Ovarian Cancer

Poon Chian Hui - Straits Times Indonesia | November 18, 2011

More women in Singapore are coming down with an aggressive form of ovarian cancer whose symptoms are vague and survival rate low.

In 1988, 5.2 percent of all ovarian cancers were of the type called clear cell carcinoma. In 2007, the figure went up to 13.4 percent.

Less than 40 percent of women who get it survive, even when the cancer is detected early, said Associate Professor Tay Sun Kuie of the Singapore General Hospital (SGH).

In contrast, other types of ovarian cancer have a survival rate of as high as 70 percent when discovered early.

Prof Tay led a study which looked at the profiles of 256 ovarian cancer patients seen at SGH from 2004 to 2009, and examined national trends based on data from the Singapore Cancer Registry from 1988.

Ovarian cancer is the fifth most common among women in Singapore after breast, colorectal, lung and uterus, and nearly 300 are diagnosed with it every year.

It affects one out of 18 female cancer patients, and some 40 percent of cases occur in those aged 55 and above. The clear cell type usually crops up earlier, in those aged 40 onwards.

The symptoms for clear cell carcinoma are vague, but it has been found to occur in women who have painful and irregular periods and who are mysteriously losing weight or their appetite.

The study also found that women who were never pregnant are 14 percent more likely to get this aggressive cancer, compared with ovarian cancer patients who had at least one child.

There is also a link to endometriosis, a disorder where the womb lining responsible for menstruation is found outside the womb, leading to severe menstrual cramps, chronic pain in the pelvic region and infertility.

Patients who have the clear cell type are nearly five times more likely to have endometriosis than those with other types of ovarian cancer.

Clear cell carcinoma is the most lethal of all ovarian cancers. Even with surgery and chemotherapy, up to 80 percent of sufferers fail to improve, even if they were diagnosed at an early stage.

Prof Tay, a senior consultant in obstetrics and gynaecology, said the cancer cells have special genes that makes them more resistant to chemotherapy drugs. "Giving the cancer cells medicine is like giving them water - it doesn't kill them," he said.

SGH decided to research clear cell carcinoma because the cancerous cysts resemble ordinary ones in ultrasound and computed tomography (CT) scans.

Cysts in the ovaries are common and normally harmless.

"The cyst looks just like an empty fish bowl," said Prof Tay. "It can confuse doctors... because of the seemingly harmless appearance."

This was the case for a patient known only as Madam Lim in the study, which was first presented at the Singapore International Congress of Obstetrics and Gynaecology in August.

The 41-year-old manager, who was married but never pregnant, had a history of endometriosis.

When her pain flared up again, she underwent ultrasound and CT scans which revealed a large cyst measuring 15cm in diameter.

During the operation to remove it, doctors realized she actually had clear cell ovarian cancer.

Her condition is currently stable after treatment.

As doctors "cannot possibly take out every cyst in all women", Prof Tay hoped the study would help doctors in better diagnosing this cancer by pointing out, for example, the link with endometriosis.

He said women who experience an unexplained loss of appetite and worsening symptoms of endometriosis may want to seek medical advice early.

"This doesn't mean that one should be alarmist, but women ought to be more aware of changes in their body," he said.

Reprinted courtesy of Straits Times Indonesia. To subscribe to Straits Times Indonesia and/or the Jakarta Globe call 021 2553 5055.


http://www.thejakartaglobe.com/international/rise-in-dangerous-type-of-ovarian-cancer/479337#Scene_1